Could nicotine be beneficial for Behçet's disease?
Kaklamani
V G
VG
Markomichelakis
N
N
Kaklamanis
P G
PG
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D003078:Colchicine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009538:Nicotine / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011446:Prospective Studies; D012907:Smoking; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009538:Nicotine; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D003078:Colchicine